Introduction
Childhood cancer is a leading cause of pediatric mortality, and the incidence has steadily increased since 1975 [
1]. Pediatric malignant tumors primarily occur during the first year of life, with a second peak observed between ages 2 and 3. These tumors include various conditions, such as acute leukemias, malignant lymphomas, encephalomas, neuroblastomas, kidney tumors, and malignant bone cancers. Neuroblastomas and Wilms tumors are more prevalent before the age of 5 years, whereas brain tumors and malignant lymphomas are more common after this age [
2]. Neuroblastoma-a malignant tumor of the sympathetic nervous system and the most common extracranial solid tumor in children-originates from embryonic neural crest cells. Recent advancements in treatment strategies for neuroblastoma have resulted in a 5-year survival rate of 82% in children aged < 15 years [
3]. Treatment strategies for this malignancy include chemotherapy, radiation therapy (RT), hematopoietic stem cell transplantation (HSCT), and immunotherapy [
4]. Meanwhile, dental developmental disturbances caused by these treatments include microdontia, short roots, root shunting, delayed or arrested dental development, enamel hypoplasia, abnormal crown size, and multiple tooth agenesis [
5-
7]. A previous study reported that the incidence of hypodontia and microdontia was higher in cancer survivors who received anticancer treatment before the age of 4 years [
8].
Short root anomalies were typically addressed by extraction, particularly when tooth preservation was challenging because of severe mobility. In such cases, the rehabilitation of oral function was achieved using prosthetic devices such as flexible or implant-supported dentures [
9,
10]. However, tooth preservation is crucial for pediatric patients receiving anticancer treatment at an early age because alveolar bone resorption can occur after extraction.
This report presents two cases of pediatric patients who were diagnosed with neuroblastoma and exhibited severe tooth mobility due to short roots as a complication of cancer treatment. Moreover, herein, we discuss the conservative management of patients using resin wire splints and orthodontic miniscrews along with long-term follow-ups to evaluate their prognosis.
Discussion
Neuroblastoma is one of the most common malignant tumors in children and originates from primitive nervous system cells, with an average age at diagnosis of 17 months [
11,
12]. The first phase of tooth development begins around the 6th week of gestation, whereas tooth root development continues until approximately 3 years of age. Permanent dental crowns form over a period of approximately 12 years. Meanwhile, the development of the roots of all teeth, except the third molars, begins at approximately 3 - 4 years of age and continues until the age of 16 years [
13]. The diagnosis of neuroblastoma often coincides with critical dental development phases. Moreover, common neuroblastoma treatments, such as RT, chemotherapy, and HSCT, can markedly impact dental development [
6]. RT with high-dose radiation exposure during early tooth development stages, including the tooth germ phase, can lead to incomplete tooth formation [
5]. In subsequent growth stages, even lower radiation doses can cause dental abnormalities, including microdontia, short roots, enamel hypoplasia, delayed tooth development, and root resorption [
14]. Chemotherapy acts via various mechanisms, such as inhibition of cell division or destruction of DNA or RNA in cells. These treatments can lead to dental abnormalities such as delayed tooth development, dental agenesis, microdontia, supernumerary teeth, and short roots [
15]. HSCT involves administering healthy hematopoietic stem cells to patients with dysfunctional or depleted bone marrow. In general, the younger the patient at the time of HSCT, the higher the chance of agenesis or microdontia [
5,
16].
The two cases presented in this report were diagnosed with Stage IV neuroblastoma before the age of 3 years, and they received TBI doses of 3,891 and 1,500 cGy, respectively. Moreover, chemotherapy was administered, and HSCT was provided as part of the treatment before the age of 4 years. Regarding long-term complications, both cases 1 and 2 exhibited dental abnormalities, including the absence of seven or nine teeth, microdontia in five or three teeth, and short roots in all permanent teeth.
In a previous study, dental anomalies, including short root teeth, were observed in a 12-year-old boy who had undergone anticancer treatment for neuroblastoma. Teeth with mobility were extracted, and implant-supported overdentures were fabricated [
9]. However, when placing implants in growing children, the implant may submerge compared with the vertical growth of the adjacent alveolar bone, which could pose challenges to occlusion and hygiene management [
17]. Craniofacial growth is completed at ages 13 - 15 for females and 17 - 25 for males [
18]. Therefore, in these cases, the final prosthetic plan involved extracting mobile teeth and proceeding with implant placement after this age.
Various methods have been introduced to stabilize teeth with severe mobility. First, a removable splint made from polycarboxylate and polyacrylic can be used, primarily within a short period (4 - 8 weeks) for traumatized teeth [
19]. Another method is the use of a fixed periodontal splint. Various types of splints are available, such as light-cured resin or materials like wire, fiber, and titanium [
20]. The most commonly used splint among these types is RWS. For enhanced flexibility, it is generally recommended to use orthodontic wires with a thickness of < 0.018 inch, such as twistflex wire, or those with a thickness of 0.4 - 0.5-mm, allowing physiological movement while preventing complications such as ankylosis [
21]. However, in the present report, rectangular 0.017 × 0.025-inch wire was used, because the length of the root is very short, necessitating a more rigid fixation. Additionally, while SS wire is commonly used for rigidity, it can lead to increased production of free radicals and potential cytotoxicity, making it less suitable for long-term use in cancer survivors [
22]. In contrast, TMA materials, characterized by an inert TiO
2-based film on their wire surface, were chosen due to their excellent biocompatibility [
23,
24].
However, one of the limitations of this technique is that RWS is primarily intended for short-term stabilization of mobile teeth, especially in pediatric cases, but long-term use, particularly in growing children with erupting teeth, may disrupt the physiological eruption process when the device is attached to erupting teeth. Similarly, in case 2, the teeth were not connected to RWS to allow for the eruption of the lower right lateral incisors. In the future, once a complete eruption occurs, the possibility of modifying the RWS design will be considered, taking into account the assessment of mobility. Additionally, orthodontic miniscrews were chosen in both cases due to the short length of the adjacent tooth root, requiring extra anchorage.
Miniscrews offer several advantages, including costeffectiveness, easy placement and removal, small and versatile size for various anatomical regions, excellent stress distribution to the surrounding bone tissues, resistance to orthodontic forces, and minimal surgical trauma [
25-
27]. However, when treating pediatric cancer survivors, it is essential to be mindful of the potential adverse effects and risks of complications associated with miniscrew placement. Miniscrews are made from the same materials as implants and are sometimes referred to as mini-implants. There are important considerations when determining implant placement for patients with a history of cancer. The first consideration is to delay surgical procedures if the patient’s platelet count is ≤ 100,000/mm3. Furthermore, a history of radiation exposure ≥ 66 Gy to the head and neck may pose a risk of radiationinduced osteonecrosis after implant placement [
28]. Although there is a shortage of research on the long-term use of miniscrews, it remains critical to select suitable patients for miniscrew placement based on their medical history and condition. The two patients had completed anticancer treatments, including chemotherapy and RT, before 3 and 4 years, respectively, and were not receiving any medications at the time of miniscrew implantation.
Several factors should be considered when implanting a miniscrew. The first is the implantation site. When the implantation site is in close contact with the root, it can lead to loss of tooth vitality, root fractures, and loss of dental sensation. Also, placing miniscrews in the nonkeratinized tissue may exert pressure on the surrounding tissues, potentially causing tissue overgrowth [
29]. In case 2, due to the short length of the attached gingiva, the miniscrew was positioned in the alveolar mucosa to prevent it from getting too close to the tooth root. Should there be an excessive growth of soft tissue, the plan involves removing the excess tissue and, in the future, relocating the miniscrew based on the expansion of the attached gingiva as the alveolar bone growth.
The second consideration is the miniscrew diameter. To minimize minor bone damage, it’s advisable to use a 1.5- or 1.6-mm-diameter miniscrew, with a preference for the latter in these cases [
30,
31]. If the diameter is too small, there is a risk of screw loosening or detachment [
32]. However, in both cases, miniscrews were employed for tooth maintenance rather than applying orthodontic forces, thus minimizing related risks.
Even after implantation, thorough oral hygiene management and inflammation control are crucial, with the removal of the screw being considered in patients with suspected infections. If there is local irritation, it is common to use 0.2% chlorhexidine to manage local inflammation. However, it is essential to exercise caution when dealing with patients who have inadequate oral hygiene management. In particular, because a wire is connected around the miniscrew neck, there is a risk of tissue damage and plaque deposition [
33]. To prevent this, exposing the miniscrew head as much as possible can be beneficial [
34]. For case 1, although the miniscrew was initially placed in the attached gingiva, over a five-year observation period, excessive tissue growth in the surrounding area was noted. Therefore, consideration should be given to exposing the miniscrew head a bit more to facilitate oral hygiene maintenance.
In both cases, despite C/R ratios significantly lower than the normal 0.5 [
25], follow-up exams at 8 and 3 years, respectively, showed miniscrews effectively reduced tooth mobility. This report suggests that the utilization of miniscrews and RWS may offer benefits not only to pediatric cancer survivors but also to those with short dental roots by enabling the preservation of teeth.